Becton, Dickinson and Company: Peripheral Arterial Disease trials

The registry lists 19 Peripheral Arterial Disease studies with Becton, Dickinson and Company as lead sponsor. 1 are open to participants now and 7 have results posted.

No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)RecruitingNCT07016698Not applicable
• Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA BalloonCompletedNCT03193619Results posted
• BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive DiseaseCompletedNCT02655887Not applicableResults posted
• Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon CatheterCompletedNCT02424383Not applicableResults posted
• BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive DiseaseCompletedNCT02228564Not applicableResults posted
• LEVANT 2 Safety RegistryCompletedNCT01790243Not applicableResults posted
• LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)CompletedNCT01628159Not applicableResults posted
• Bard® LifeStent® Vascular Stent Delivery System StudyCompletedNCT01179984Not applicableResults posted
• Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal ArteriesCompletedNCT05556681Not applicable
• FLUENCY® PLUS in the Treatment of Peripheral Artery DiseaseCompletedNCT04765566
• Post-Market Clinical Follow Up of Rotarex®S CatheterCompletedNCT04010123
• Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent SystemCompletedNCT03071146
• Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB in Femoropopliteal ArteriesCompletedNCT02717104
• Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK ArteriesCompletedNCT02554266
• Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal ArteriesCompletedNCT02278991
• A Prospective Study of the Bard® LifeStent® Solo Vascular Stent SystemCompletedNCT02262949Not applicable
• Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower ExtremityTerminatedNCT02043951
• A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY)CompletedNCT01920308
• Lutonix Global SFA RegistryCompletedNCT01864278